The online version of this article (doi:10.1186/1475-2875-11-1) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
VS identified literature sources, conceived acquisition of data, participated in the sequence alignment and drafted the manuscript. MS conceived of the study, and participated in its design and coordination and helped to draft the manuscript. EN participated in the interpretation of data. JS participated in the design of the study and performed the statistical analysis and contributed to the writing of the manuscript. HH conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
To document the status of imported malaria infections and estimate the costs of treating of patients hospitalized with the diagnosis of imported malaria in the Slovak Republic during 2003 to 2008.
Calculating and comparing the direct and indirect costs of treatment of patients diagnosed with imported malaria (ICD-10: B50 - B54) who used and not used chemoprophylaxis. The target sample included 19 patients diagnosed with imported malaria from 2003 to 2008, with 11 whose treatment did not include chemoprophylaxis and eight whose treatment did.
The mean direct cost of malaria treatment for patients without chemoprophylaxis was 1,776.0 EUR, and the mean indirect cost 524.2 EUR. In patients with chemoprophylaxis the mean direct cost was 405.6 EUR, and the mean indirect cost 257.4 EUR.
The analysis confirmed statistically-significant differences between the direct and indirect costs of treatment with and without chemoprophylaxis for patients with imported malaria.
Act No. 461/2003. Collection of Acts Slovak Republic. 2008, 1386-1545.
Act No. 462/2003. Collection of Acts Slovak Republic. 2003, 3704-3708.
Statistical Office of the Slovak Republic: Indicators of Economic Development of the SR. 2011, Available at: http://portal.statistics.sk/showdoc.do?docid=19 [accessed on 30 April 2011]
World Health Organization: International Travel and Health: Situation as on 1 January 2010. 2010, World Health Organization, Geneva
Neghina R, Neghina AM, Marincu I, Iacobiciu I: International Travel Increase and Malaria Importation in Romania, 2008-2009. Vector-Borne and Zoonotic Diseases. Available at: http://www.liebertonline.com/doi/abs/10.1089/vbz.2010.0275; 2011 [accessed on 10 August 2011]
World Health Organization: Global Malaria Control and Elimination: Report of a Technical Review. 2008, World Health Organization, Geneva
Centres for Disease Control and Prevention: Malaria facts. CDC, Available at: http://www.cdc.gov/malaria; 2010 [accessed on 28 April 2011]
Hollyman S, Gathany J, Buj V: World Health Organization. 10 Facts on Malaria. 2009, Available at: http://www.who.int/features/factfiles/malaria (accessed on 28 April 2011)
Shepard DS, Ettling MB, Brinkmann U, Sauerborn R: The economic costs of malaria in Africa. Trop Med Parasitol. 1991, 42: 199-203. PubMed
Mustafa MH, Babiker MA: Economic costs of malaria on households during a transmission season in Khartoum State, Sudan. East Mediterr Health J. 2007, 13: 1298-1307. PubMed
Guiguemde TR, Coulibaly N, Coulibaly SO, Ouedraogo JB, Gbary AR: A precise method for estimating the economic costs of malaria: Application of the method in a rural area in Burkina Faso (West Africa). Trop Med Int Health. 1997, 2: 66-653. CrossRef
Sicuri E, Davy C, Marinelli M, Oa O, Ome M, Siba P, Conteh L, Mueller I: The economic cost to households of childhood malaria in Papua New Guinea: a focus on intra-country variation. Health Policy Plan. 2011, 10.1093/heapol/czr046 Available at: http://heapol.oxfordjournals.org/content/early/2011/06/22/heapol.czr046.full; 2011; [accessed on 30 June 2011]
Dinkel R, Banz K, Buchner K, Sfeffen R, Gutzwiller F: Kosten-Nutzen-Analyse der Malariaprophylaxe bei Keniareisenden mit Mefloquin. Soz Praeventivmed. 1990, 35: 213-219. 10.1007/BF01369089. CrossRef
Croft AM, Winfield CR, Horsfall M, Quarrell MA: Direct health costs of occupationally acquired malaria in a military population in Europe. Occup Med. 2005, 55: 128-130. 10.1093/occmed/kqi027. CrossRef
Ministry of Health Slovak Republic: Bulletin of the Ministry of Health Slovak Republic: Regulation of the Ministry of Health Slovak Republic No. OPL0208-13444/2008-OL. 2008, Bratislava: Obzor
Pistone T, Schwarzinger M, Chauvin P, Ezzedine K, Receveur MC, Djossou F, Siriwardana M, Larouze B, Malvy D: Reimbursement of malaria chemoprophylaxis for travellers from Europe to Sub-Saharan Africa: Cost-effectiveness analysis from the perspective of the French national health insurance system. Health Policy. 2008, 88: 186-199. 10.1016/j.healthpol.2008.03.002. CrossRefPubMed
- Costs analysis of the treatment of imported malaria
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II